ALINS Intrasense S.A.
Intrasense S.A. designs and develops software solution for advanced visualization and analysis of multimodality medical images under the Myrian name worldwide. It offers the Myriad platform, a visualization solution that provides a suite of clinical tools and artificial intelligence algorithms for prostate, lung, and brain pathologies; and the Liflow solution, an oncological imaging platform that automates the identification and measurement of lesions. Intrasense S.A. was incorporated in 2004 and is headquartered in Montpellier, France. Intrasense S.A. operates as a subsidiary of Guerbet SA.…
Industry Peers
Health Information ServicesKey Statistics
About Intrasense (EPA: ALINS)
›
Intrasense (EPA: ALINS) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 76 employees.
The shares were at 0.1985 EUR on 19 November 2026, down 22.8% over 52 weeks. Its 52-week range is 0.1820 EUR to 0.4710 EUR: the price is 57.9% below the high and 9.1% above the low.
Its market capitalisation is 10.47M EUR.
Intrasense reports return on equity of 167.4%, an operating margin of -237.6% and revenue up 33.3% year over year.
It holds more cash than debt, a net cash position of 71.00K EUR. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.